This site is intended for U.S. Healthcare Professionals only.

  • U.S. Full Prescribing Information |
  • Medication Guide |
  • Indication

    Indication

    SOTYKTU is indicated for the treatment of moderate-to-severe plaque psoriasis in adults who are candidates for systemic therapy or phototherapy.

    Limitations of Use: SOTYKTU is not recommended for use in combination with other potent immunosuppressants.

This website is best viewed
using the horizontal display
on your tablet device.

This website is best viewed
using the vertical display
on your mobile device.

Resources
for your practice

Starting a new treatment can be filled with questions—about treatment,
tracking goals, and insurance. To help you patients start and manage
treatment with SOTYKTU here are a few resources to help.

Resources
for your practice

Starting a new treatment can be filled with questions—about treatment,
tracking goals, and insurance. To help you patients start and manage
treatment with SOTYKTU here are a few resources to help.

Getting started

Resources and support

Downloadable resources for patients
SOTYKTU 360 Support
Patients taking SOTYKTU are invited to enroll in SOTYKTU 360 Support, with a support team to help guide them, insurance resources to inform them, savings
programs to help them, and continued communications to encourage them.
Get To Know Sotyktu Brochure
Call it SOTYKTU 101—an introduction to the basics of how SOTYKTU works, why it may be right for your patients, and an overview of the SOTYKTU $0 co-pay card.
Sotyktu 360 Support Getting Started Guide
A handy checklist to help patients enroll in the SOTYKTU 360 Support program, this guide can help patients make the most of the benefits available to them.
My Experience Tracker
This ringed binder is full of tips, tools, and refillable pages to help your patients track their treatment goals so they can have more thoughtful conversations with you regarding their progress.
SOTYKTU $0 Co-Pay Assistance Program
Eligible patients with commercial
insurance may pay as little as $0 a month* for SOTYKTU when the SOTYKTU 360 Support co-pay assistance card is used.
CoverMyMeds overview
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco
Advocacy groups for you
Interested in staying in the know about and connecting with advocacy groups?
Visit the Advocacy a page to get more information.
Bristol Myers Squibb™ Logo

SOTYKTU, SOTYKTU 360 SUPPORT, and SOTYKTU
logo
are trademarks of Bristol-Myers Squibb Company.

Otezla is a registered trademark of Amgen Inc.

© 2023 Bristol-Myers Squibb Company.

1787-US-2300483 07/23

1787-US-2300303 06/23

1787-US-2300737 10/23

1787-US-2300483 07/23

1787-US-2300303 06/23